PERTINENT FINDINGS: In this multicenter, international study including 1,960 men with BCR or BCP of prostate cancer, we found that high-risk EAU BCR and BCP was significantly associated with a higher risk of metastatic disease on PSMA PET. This evidence concerns the gene FOLH1 and metastatic neoplasm.